About Emerge Diagnostics
Emerge Diagnostics is a Healthcare company based in Carlsbad (United States) founded in 2012. It operates as a soft tissue injuries are diagnosed via a specialized electrodiagnostic device. Emerge Diagnostics has raised $6.74 million across 6 funding rounds. Emerge Diagnostics offers products and services including EFA Technology. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Screening Devices. Its legal entity is EMERGE DIAGNOSTICS, INC. Its competitors include EOS Iamging, OXOS Medical, Scolioscan, Aclarion and Knee Voice and 4 more; 6 of its 9 listed competitors have raised funding.
Company details
Emerge Diagnostics was founded in 2012 in Carlsbad, United States, within the medical diagnostics sector. A device called Electrodiagnostic Functional Assessment is developed to evaluate muscle activity in soft tissue injuries. Acute and chronic conditions are distinguished, while effort levels are quantified. Pre- and post-injury assessments are offered to verify workplace-related incidents through objective testing.
- Headquarters Carlsbad, United States
- SectorsHealthcare
- Website emergedx.com
- Social LinkedIn X YouTube
- Legal Name Emerge Diagnostics, Inc
- Total Equity Funding$6.74M (USD)
in 6 rounds
- Latest Funding Round$200.4K (USD), Series A
Mar 2021
Products & Services of Emerge Diagnostics
Emerge Diagnostics offers a comprehensive portfolio of products and services, including EFA Technology.
Noninvasive system for assessing musculoskeletal conditions accurately
Funding Insights of Emerge Diagnostics
Emerge Diagnostics has successfully raised a total of $6.74M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $200.4 thousand completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6.74M
- Total Rounds 6
- Last Round Series A — $200,396
- First Round $885,000
(Jul 2014)
All 6 funding rounds of Emerge Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2021 | $200,396 | Series A | – | – | – |
| Sep 2020 | $550,000 | Series A | – | – | – |
| Jun 2017 | $250,000 | Series A | – | – | – |
| Jun 2016 | $1.85M | Series A | – | – | – |
| Dec 2014 | $3M | Series A | – | – | – |
| Jul 2014 | $885,000 | Seed | – | – | – |
People of Emerge Diagnostics
8 people are tracked at Emerge Diagnostics (4 in leadership, 4 in team).
| Name | Role | Group |
|---|---|---|
Bret Oettmeier | CEO | Leadership |
Sheila Harless | Director, Operations | Leadership |
Maria Banken | Director Of Accounting | Leadership |
Landon Middleton | Sr. Director Of Marketing | Leadership |
Megan Pearsall | Wellness Program Manager I EFA Coordinator | Team |
Makenzie B. | EFA Screening Technician | Team |
Vanessa Alvarez | EFA Program Manager | Team |
Brian Sagun | Quality Technician | Team |
Complete people profiles for Emerge Diagnostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Emerge Diagnostics
3 dated milestones of Emerge Diagnostics across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Emerge Diagnostics is founded.
- Funding First funding round of $885K.
- Funding Latest funding round, Series A, of $200K.
Competitors of Emerge Diagnostics
Emerge Diagnostics has 9 listed competitors in our database, 6 of them funded. They include EOS Iamging, OXOS Medical, Scolioscan, Aclarion and Knee Voice, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| eos-imaging.com | 1989 | Paris, France | $43.8M | – | 2D/3D orthopedic imaging systems and software solutions are developed. | |
| oxos.com | 2001 | Atlanta, United States | $42.46M | – | Orthopedic imaging devices and software are developed for surgical use. | |
| scolioscan.com | 2012 | Hong Kong, China | $5.52M | – | Radiation-free 3D ultrasound scoliosis assessment is developed. | |
| aclarion.com | 2008 | Broomfield, United States | $3.26M | 6 | SaaS-based radiology image analysis tools are provided for medical providers. | |
| kneevoice.com | 2015 | Santa Monica, United States | $1.87M | 7 | Knee health is monitored via a wearable device during activities. | |
| forethoughtmed.com | 2023 | China | – | – | Solutions for spinal health measurement and examination are provided. | |
| dsmedco.com | 2012 | Poway, United States | $11.52M | – | Acoustic coherent tomography imaging systems are provided for medical diagnostics. | |
| kneedly.se | 2021 | Gothenburg, Sweden | – | – | Knee ligament injuries are diagnosed by software for healthcare professionals. | |
| maknee.fi | 2017 | Oulu, Finland | – | – | It serves as a limited information available. |
Detailed competitors of Emerge Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Orthopedics
10 companies that operate in the same segment as Emerge Diagnostics (Orthopedics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Prosthetic and orthotic devices are developed for individuals with disabilities. | 1919 | Duderstadt, Lower Saxony, Germany | USD 17 M | USD 1.97 B | – | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Developer of drugs for treating rare and autoimmune diseases | 2008 | Dublin, Ireland | USD 61.78 M | USD 617.41 M | – | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M | – | – | |
Robotic arms are provided for mobility and rehabilitation support. | 2004 | Boston, Massachusetts, United States | USD 17.21 M | USD 40.93 M | 185 | |
AI-powered drug discovery platform for various diseases | 2016 | New York, New York, United States | USD 608 M | – | – | |
Exoskeletons for medical rehabilitation and industrial productivity are provided. | 2005 | United States | USD 24.37 M | USD 71.6 M | 61 | |
Stabilization devices for healthcare are manufactured by the company. | 2005 | New York, New York, United States | USD 142.15 M | – | 43 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Emerge Diagnostics
Complete news archive for Emerge Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Emerge Diagnostics
Emerge Diagnostics was founded in 2012 and raised its 1st funding round 2 years after it was founded.
Emerge Diagnostics is headquartered in Carlsbad, United States. It is registered at Carlsbad, California, United States.
Emerge Diagnostics is a funded company, having raised a total of $6.74M across 6 funding rounds to date. The company's 1st funding round was a Seed of $885K, raised on Jul 2014.
Emerge Diagnostics was founded in 2012 in Carlsbad, United States, within the medical diagnostics sector. A device called Electrodiagnostic Functional Assessment is developed to evaluate muscle activity in soft tissue injuries. Acute and chronic conditions are distinguished, while effort levels are quantified. Pre- and post-injury assessments are offered to verify workplace-related incidents through objective testing.
Emerge Diagnostics's top competitors include EOS Iamging, OXOS Medical and Aclarion.
Emerge Diagnostics offers EFA Technology.
Emerge Diagnostics operates through Emerge Diagnostics, Inc.